8/1/2021Can AstraZeneca Sustain Rapid Growth in China amid Price-Cutting Schem...

7/30/2021China Begins to Deploy Patent Linkage as NMPA Tempted to Set Higher Ba...

7/30/2021Financial-related Company News in Brief (July 2021)

7/30/2021Review of Chinese Drug Registration Application and Evaluation in H1/2...

7/30/2021Recent Executive Moves

7/29/2021SMEI: Chinese Drug Market under Transformation with Growing ex-Hospita...

7/29/2021Junshi's Chinese sNDA for Toripalimab Plus Chemotherapy as First-Lin...

7/29/2021Guobang Pharma's IPO to Debut on Shanghai Stock Exchange

7/29/2021AstraZeneca's China Business Growth Slows in Q2/2021 amid VBP Uncertai...

7/29/2021Ping An-Shionogi Joint Venture Launched in Shanghai

7/29/2021Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D a...

7/29/2021Complix Signs Global Drug R&D Pact with Nhwa Pharma to Develop Novel A...

7/29/2021Parexel Enters Patient Centric Partnership with CAMS Cancer Hospital

7/29/2021Novita and CR Double Crane in License Deal for Fascin Inhibitor in C...

7/29/2021I-Mab's Chinese IND for P2 Trial of Efineptakin Alfa in Combo with PD-...

7/29/2021Health Care in the Year of the Ox: Navigating China's Dynamic M&A Mark...

7/29/2021China's New Grounds for Defence and Damages Indicates Tougher Rules on...

7/29/2021Antibody Licensing Deals in China: H1 2021 Summary by PharmaDJ/CAS

7/29/2021China's 2021-2025 Five-Year Plan - An Outlook to China's Planned Futur...

7/28/2021NHC Issues the Guidelines for Comprehensive Clinical Appraisal of Drug...

7/28/2021Daewoong Reports Positive Chinese Ph3 Trial Outcome of Its Botulinum...

7/27/2021NMPA Revises Packages Insert of Vitamin B6 Injection

7/27/2021NMPA Issues the Announcement on Certain Matters Related to Drug-Device...

7/27/2021HUTCHMED and AZ Initiate Phase II Trial of ORPATHYS for MET Amplified ...

7/27/2021NASDAQ-listed I-Mab to Seek Dual Listing on Shanghai's STAR Market

7/27/2021Sanofi Secures A New Indication for Renvela (sevelamer) in China

7/27/2021Set Up Steps for Biotech Businesses in China

7/27/2021Understanding "Internet Plus Healthcare" in China: Policy Text Analysi...

7/23/2021Novartis Reports Strong H1 & Q2 Global and China Performance

7/23/2021Roche Reports Flat H1 Performance with Moderate China Drug Sales Growt...

Page:121/719 Total number of articles:21549: [First][<<] [119] [120] [121] [122] [123] [>>] [End]